Our 7th Annual Partnership Opportunities in Drug Delivery (PODD) event will take place on October 19-20, 2017 at the Marriott Copley Place in Boston.

This annual Boston-based conference is designed with three purposes:

To present a strategic level program for pharma and biotech business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
To offer ample networking time, facilities and services for one-on-one meetings to establish new business contacts and enhance existing ones.

The 7th annual event will be chaired by Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche. New to PODD this year, keynoting is Dr Jeffrey Karp, a bioengineer and world leader in drug delivery, stem cell therapeutics, and tissue adhesives. We are also delighted to welcome two additional keynote speakers: Lars Rebien Sorensen, former President and CEO of Novo Nordisk and Dr Omid Farokhzad, Associate Professor at Harvard Medical School and Director of the Center for Nanomedicine at BWH.

Our distinguished speaking faculty also includes the following Technology Track Chairs: Justin Wright, PhD, VP, Drug Delivery Innovation, DDR&D Technology at Eli Lilly; Mathias Romacker, Senior Director, Device Strategy at Pfizer; Matthew Burke, PhD, Head of Drug Delivery at GSK; Rene Holm, PhD, Head and Scientific Director, Drug Product Development, Liquids and Parenterals at Janssen; and Robert Saklatvala, PhD, Director, Discovery Pharmaceutical Sciences at Merck.

Please contact us at service@tcfllc.org if you have any questions. Registration is open and take advantage of the earliest rates